- Overview
Lyvgen Biopharma engaged in development of innovative cancer treatment, aims to in-license advanced clinical candidate drugs in order to enrich our pipeline. Please contact us to explore collaboration opportunities.
礼进生物（Lyvgen）的网站
Lyvgen is a biopharmaceutical company focused on developing novel therapies for cancer. Lyvgen’s xLinkAb™ functional platform creates agonist antibodies (Abs) with tumor-localized immunostimulatory activities by balancing multiple functions of candidate Abs.
https://user-assets.sxlcdn.com/images/676507/FiTA8WK-FQRyXrQDyd-HDkY3tpfI.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png